• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analyses of genomic alteration and mechanisms responsible for hepatocarcinogenesis using deep sequencing and human iPS cells

Research Project

Project/Area Number 19H03635
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionTokyo Medical and Dental University

Principal Investigator

Asahina Yasuhiro  東京医科歯科大学, 大学院医歯学総合研究科, 寄附講座教授 (00422692)

Co-Investigator(Kenkyū-buntansha) 柿沼 晴  東京医科歯科大学, 大学院医歯学総合研究科, 教授 (30372444)
中川 美奈  東京医科歯科大学, 統合教育機構, 准教授 (30401342)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2021: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2020: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2019: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Keywords肝がん / ヒトiPS細胞 / HBV ingtegration / 肝細胞癌 / 肝炎ウイルス / オルガノイド / 肝癌 / HBV / HCV / 肝線維化
Outline of Research at the Start

肝炎ウイルスに対する抗ウイルス療法は進歩したが、ウイルス非存在下や制御下においても肝病態の進展や発癌はおこる。しかし、これら病態進展や発癌に関わる因子やそのメカニズムは未だ十分に明らかではない。本研究では、肝疾患における肝発癌・病態進展に関わる宿主およびウイルス要因を解明するとともに、ヒトiPS細胞を用いて疾患病態の解析を可能とする培養法を開発し機能解析を進める。現在の治療とは発想を異にする新規治療法の開発に向けた知的基盤を得ることをめざす。

Outline of Final Research Achievements

In this study, genomic factors involved in hepatocarcinogenesis were investigated. We analyzed HCC samples obtained by hepatic resection using a semiconductor sequencer, and clarified the differences in genomic factors among different viral conditions. Based on these findings, genetically mimicked human iPS cells were constructed, and analyzed their phenotype to elucidate the mechanism responsible for hepatocarcinogenesis.

Academic Significance and Societal Importance of the Research Achievements

本研究ではHCV排除後やHBV持続感染、及び非ウイルス性肝癌に関わる癌ゲノムプロファイルを明らかとし、ヒトiPS細胞培養技術および遺伝子改変技術を応用した病態解析モデルを開発し、発癌・病態形成機構の解明を進めた。本研究により、未だ根本治療や予防法の存在しない肝癌における、これまでとは視点を異にする新規治療法開発への展開が期待されるとともに、これらの研究手法は他分野に広く応用可能である。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Annual Research Report
  • 2019 Annual Research Report
  • Research Products

    (62 results)

All 2022 2021 2020 2019

All Journal Article (14 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 14 results,  Open Access: 11 results) Presentation (37 results) (of which Int'l Joint Research: 9 results,  Invited: 7 results) Book (11 results)

  • [Journal Article] Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis2022

    • Author(s)
      Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Kato N, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Nakamoto Y, Asahina Y, et al.
    • Journal Title

      Journal of Gastroenterology

      Volume: 57 Issue: 2 Pages: 120-132

    • DOI

      10.1007/s00535-021-01845-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy2022

    • Author(s)
      Sekiguchi Shuhei、Tsuchiya Kaoru、Yasuhiro Asahina, et al.
    • Journal Title

      Cancer Reports

      Volume: in press Issue: 11

    • DOI

      10.1002/cnr2.1613

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice2021

    • Author(s)
      Hayakawa Yuka、Tsuchiya Kaoru、Yasuhiro Asahina, et al.
    • Journal Title

      Investigational New Drugs

      Volume: 40 Issue: 2 Pages: 392-402

    • DOI

      10.1007/s10637-021-01185-4

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis2021

    • Author(s)
      Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Marino Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, et al
    • Journal Title

      Gut

      Volume: in press Issue: 3 Pages: 323663-323663

    • DOI

      10.1136/gutjnl-2020-323663

    • Related Report
      2021 Annual Research Report 2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study2020

    • Author(s)
      Tahata Yuki、Hikita Hayato、Matsuura Kentaro、Takehara Tetsuo, et al.
    • Journal Title

      Journal of Gastroenterology

      Volume: 56 Issue: 1 Pages: 67-77

    • DOI

      10.1007/s00535-020-01733-4

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs2020

    • Author(s)
      Nakagawa M, Nawa N, Takeichi E, Shimizu T, Tsuchiya J, Sato A, Miyoshi M, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Fujiwara T, Watanabe M, Tanaka Y, Asahina Y; Ochanomizu Liver Conference Study Group.
    • Journal Title

      Journal of Gastroenterology

      Volume: 55 Issue: 10 Pages: 990-999

    • DOI

      10.1007/s00535-020-01715-6

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials2020

    • Author(s)
      Asahina Yasuhiro、Liu Chun‐Jen、Gane Edward、Itoh Yoshito、Kawada Norifumi、Ueno Yoshiyuki、Youn Jin、Wang Chen‐Yu、Llewellyn Joe、Matsuda Takuma、Gaggar Anuj、Mo Hongmei、Dvory‐Sobol Hadas、Crans Gerald、Chuang Wan‐Long、Chen Pei‐Jer、Enomoto Nobuyuki
    • Journal Title

      Hepatology Research

      Volume: 50 Issue: 10 Pages: 1109-1117

    • DOI

      10.1111/hepr.13546

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma2020

    • Author(s)
      Kirino S, Tsuchiya K, Kurosaki M, Kaneko S, Inada K, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Okada M, Wang W, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N.
    • Journal Title

      PLoS One

      Volume: 15 Issue: 4 Pages: e0231828-e0231828

    • DOI

      10.1371/journal.pone.0231828

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: The Phase IIa OMEGA-3 study.2020

    • Author(s)
      Takehara T, Chayama K, Kurosaki M, Yatsuhashi H, Tanaka Y, Hiramatsu N, Sakamoto N, Asahina Y, Nozaki A, Nakano T, Hagiwara Y, Shimizu H, Yoshida H, Huang Y, Biermer M, Vijgen L, Hayashi N.
    • Journal Title

      J Gastroenterol

      Volume: - Issue: 6 Pages: 640-652

    • DOI

      10.1007/s00535-020-01672-0

    • Related Report
      2020 Annual Research Report 2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient2020

    • Author(s)
      Nitta Sayuri、Takahashi Kazuaki、Kawai‐Kitahata Fukiko、Tsuchiya Jun、Sato Ayako、Miyoshi Masato、Murakawa Miyako、Itsui Yasuhiro、Nakagawa Mina、Azuma Seishin、Kakinuma Sei、Watanabe Mamoru、Asahina Yasuhiro
    • Journal Title

      Hepatology Research

      Volume: 50 Issue: 4 Pages: 524-531

    • DOI

      10.1111/hepr.13480

    • Related Report
      2020 Annual Research Report 2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts2020

    • Author(s)
      Sato A, Kakinuma S, Miyoshi M, Kamiya A, Tsunoda T, Kaneko S, Tsuchiya J, Shimizu T, Takeichi E, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Koshikawa N, Seiki S, Nakauchi H, Asahina Y, Watanabe M.
    • Journal Title

      Hepatology Communications

      Volume: 4 Issue: 2 Pages: 235-254

    • DOI

      10.1002/hep4.1459

    • Related Report
      2020 Annual Research Report 2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma?Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice2019

    • Author(s)
      Wang、Tsuchiya、Kurosaki、Yasui、Inada、Kirino、Yamashita、Sekiguchi、Hayakawa、Osawa、Okada、Higuchi、Takaura、Maeyashiki、Kaneko、Tamaki、Nakanishi、Itakura、Takahashi、Asahina、Enomoto、Izumi
    • Journal Title

      Cancers

      Volume: 11 Issue: 10 Pages: 1517-1517

    • DOI

      10.3390/cancers11101517

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma‐like area and metachronous hepatocellular carcinoma2019

    • Author(s)
      Kawai-Kitahata F, Asahina Y, Kaneko S, Tsuchiya J, Sato A, Miyoshi M, Tsunoda T, Inoue-Shinomiya E, Murakawa M, Nitta S, Itsui Y, Nakagawa M, Azuma S, Kakinuma S, Tanabe M, Sugawara E, Takemoto A, Ojima H, Sakamoto M, Muraoka M, Takano S, Maekawa S, Enomoto N and Watanabe M.
    • Journal Title

      Hepatology Research

      Volume: 49 Issue: 12 Pages: 1466-1474

    • DOI

      10.1111/hepr.13403

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients2019

    • Author(s)
      Nitta S, Asahina Y, Kato T, Tsuchiya J, Inoue-Shinomiya E, Sato A, Tsunoda T, Miyoshi M, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Kakinuma S, Hikita H, Takehara T, Watanabe M.
    • Journal Title

      Scientific Reports

      Volume: 9 Issue: 1 Pages: 5722-5722

    • DOI

      10.1038/s41598-019-42114-z

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] Factors associated with HCC development and patientsʼ survival in patients with an SVR.2021

    • Author(s)
      Nakagawa M, Miyoshi M, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Asahina Y.
    • Organizer
      JSH International Liver Conference 2021
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] The real-world impact of direct-acting antiviral treatment on liver-related event in patients with hepatitis C virus-associated cirrhosis.2021

    • Author(s)
      Tahata, Y, Hikita, H, Asahina Y, et al.
    • Organizer
      AASLD The Liver Meeting 2021
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 抗ウイルス療法の進歩と新たなる課題.2021

    • Author(s)
      朝比奈靖浩.
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] 肝内胆管癌の病態と網羅的がんゲノム解析の有用性.2021

    • Author(s)
      加納嘉人、北畑富貴子、村川美也子、柿沼晴、東正新、中川美奈、井津井康浩、新田沙由梨、三好正人、田邉稔、三宅智、池田貞勝、岡本隆一、朝比奈靖浩.
    • Organizer
      第57回日本肝癌研究会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒトiPS細胞を利用したHBV関連肝細胞におけるMLL4の機能的意義の検討.2021

    • Author(s)
      中川美奈,村川美也子, 朝比奈靖浩.
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒトiPS細胞を利用したHBV関連肝細胞におけるMLL4の機能的意義の検討.2021

    • Author(s)
      土屋淳,柿沼晴,朝比奈靖浩.
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 肝炎ウイルス制御下の発癌と諸問題 核酸アナログによるウイルス制御下のB型慢性肝疾患における肝発癌および病態進展に関わる臨床因子の検討.2021

    • Author(s)
      村川美也子、中川美奈、朝比奈靖浩.
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 疾患モデルへの応用を目指したヒトiPS細胞由来肝細胞オルガノイドの樹立.2021

    • Author(s)
      志水太郎、柿沼晴、朝比奈靖浩.
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 新規ヒトiPS細胞由来肝細胞オルガノイド系の構築と肝疾患研究.2021

    • Author(s)
      三好正人、柿沼晴、朝比奈靖浩.
    • Organizer
      第25回日本肝臓学会大会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒトiPS細胞由来肝細胞系譜細胞を利用した肝細胞癌発生におけるMLL4の機能解析.2021

    • Author(s)
      土屋淳、柿沼晴、朝比奈靖浩.
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] HBV genome integration肝細胞癌における遺伝子発現の特徴と発癌機序の検討.2021

    • Author(s)
      新田沙由梨、柿沼晴、朝比奈靖浩.
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒト iPS 細胞培養系を利用した B 型肝炎ウ イルス ゲノム組み込みによる発癌プロセスの解析.2021

    • Author(s)
      土屋淳,三好正人,紙谷聡英,志水太郎,新田沙由梨,北畑富貴子,渡壁慶也,持田知洋,村川美也子,中 川美奈,東正新,朝比奈靖浩,岡本隆一,柿沼晴.
    • Organizer
      第 28 回肝細胞研究会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒト肝臓プライマリオルガノイドからのiPS細胞樹立と肝疾患研究への応用2021

    • Author(s)
      張, 米山鷹介, 三好正人, 北畑富貴子, 新田沙由梨, 赤星径一, 田邊稔, 柿沼晴, 朝比奈靖浩, 武部貴則
    • Organizer
      第21回日本再生医療学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Poor improvement of on-treatment fib-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis b patients.2020

    • Author(s)
      Murakawa M, Asahina Y, et al.
    • Organizer
      EASL The International Liver Congress 2020
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Comprehensive analysis of cancer-related genes and aav/hepatitis b virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis b virus infection.2020

    • Author(s)
      Kawai-Kitahata F, Asahina Y, et al.
    • Organizer
      EASL The International Liver Congress 2020
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] C型肝炎治療のup-to-dateと治療後のマネジメント2020

    • Author(s)
      朝比奈靖浩
    • Organizer
      日本肝臓学会後期教育講演会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] C型非代償性肝硬変に対する抗ウイルス療法2020

    • Author(s)
      朝比奈靖浩
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] C型肝炎治療ガイドライン2020

    • Author(s)
      朝比奈靖浩
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] B型肝炎ウイルスの制御状態による肝細胞癌の癌関連遺伝子とviral integrationの解析2020

    • Author(s)
      北畑富貴子, 朝比奈靖浩, 柿沼晴.
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 間葉系細胞由来vasoactive intestinal peptideによる胆管形成の促進機構2020

    • Author(s)
      佐藤綾子,柿沼晴,朝比奈靖浩.
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 核酸アナログ治療下のB型慢性肝疾患における発癌予測因子の解析2020

    • Author(s)
      村川美也子, 中川美奈,朝比奈靖浩.
    • Organizer
      第106回日本消化器病学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] ヒトiPS細胞を用いた肝線維症における分子標的の探索2020

    • Author(s)
      柿沼晴, 角田知之,朝比奈靖浩.
    • Organizer
      第106回日本消化器病学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 新たなフェーズに進んだC型肝炎治療 C型慢性肝疾患SVR後の肝発癌および予後の検討2020

    • Author(s)
      中川美奈, 村川美也子,朝比奈靖浩.
    • Organizer
      第24回日本肝臓学会大会
    • Related Report
      2020 Annual Research Report
  • [Presentation] C型肝炎診療における今後の課題 SVR後の肝発癌、生存予測因子の解析2020

    • Author(s)
      中川美奈, 朝比奈靖浩, 村川美也子.
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] C型慢性肝疾患SVR後肝発癌予測因子の検討2020

    • Author(s)
      中川美奈,村川美也子,朝比奈靖浩.
    • Organizer
      第106回日本消化器病学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Do DAA therapy result in an increased risk of hepatocarcinogenesis?2019

    • Author(s)
      Asahina Y.
    • Organizer
      Asian Pacific Digestive Week 2019
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Prevention and risk for liver cancer after anti-viral therapy in patients with HBV/HCV.2019

    • Author(s)
      Asahina Y.
    • Organizer
      JSH International Liver Conference 2019
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Comprehensive analysis of cancer gene mutations and viral integration in hepatocellular carcinoma arising from non-fibrotic liver.2019

    • Author(s)
      Asahina Y, Kawai-Kitahata F, et al.
    • Organizer
      The 70th Annual Meeting of the American Association for the Study of Liver Disease
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] The association of serum IFN-λ3 levels with liver fibrosis and hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents.2019

    • Author(s)
      Murakawa M, Inoue-Shinomiya E, Asahina Y, et al.
    • Organizer
      The 54th annual meeting of the European association for the study of the liver
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Impact of HCV clearance on HCC development and patient survival: propensity score-matched analysis of an ongoing database of 2,173 CHC patients.2019

    • Author(s)
      Nakagawa M, Asahina Y, et al
    • Organizer
      The 54th annual meeting of the European association for the study of the liver
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 核酸アナログ治療中および非治療のB型慢性肝疾患症例における発癌寄与因子の解析.2019

    • Author(s)
      村川美也子, 朝比奈靖浩, 渡辺守.
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] C型肝炎の抗ウイルス療法:DAA治療の最前線と今後の課題 C型肝炎ウイルス排除後の肝発がんに関わるリスク因子と病態の解析.2019

    • Author(s)
      朝比奈靖浩, 村川 美也子, 中川 美奈.
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 門脈圧亢進症:内視鏡治療、IVR治療、手術療法の到達点と課題 部分的脾動脈塞栓術(PSE)による肝機能改善効果及び血管径からみた解析.2019

    • Author(s)
      先田信哉, 朝比奈靖浩, 渡辺守.
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ウイルス制御下における肝発癌および長期予後 前向きコホートを用いたIFNベース治療とIFNフリー治療の比較検討.2019

    • Author(s)
      中川美奈, 朝比奈靖浩, 村川美也子.
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] C型慢性肝疾患SVR後のde novo発癌、再発癌の検討.2019

    • Author(s)
      中川美奈, 朝比奈靖浩, 渡辺守.
    • Organizer
      第105回日本消化器病学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] C型肝炎ウイルス(HCV)のNS5A領域における薬剤耐性関連変異(Resistance associated substitutions:RAS)が抗ウイルス薬効果に与える影響.2019

    • Author(s)
      新田沙由梨, 朝比奈靖浩, 渡辺守.
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] HCV-NS5A領域のP32欠失変異(P32del)とA92K変異がウイルス増殖と抗HCV薬感受性感受性に与える影響.2019

    • Author(s)
      新田沙由梨, 朝比奈靖浩, 渡辺守.
    • Organizer
      第105回日本消化器病学会総会
    • Related Report
      2019 Annual Research Report
  • [Book] 臨床検査のガイドラインJSLM20212022

    • Author(s)
      朝比奈靖浩.
    • Total Pages
      472
    • Publisher
      宇宙堂八木書店
    • Related Report
      2021 Annual Research Report
  • [Book] 臨床薬理学2021

    • Author(s)
      朝比奈靖浩.
    • Total Pages
      331
    • Publisher
      医学書院
    • Related Report
      2021 Annual Research Report
  • [Book] 最新ガイドラインに基づく 消化器疾患診療指針2021-22’2021

    • Author(s)
      朝比奈靖浩.
    • Total Pages
      365
    • Publisher
      総合医学社
    • Related Report
      2021 Annual Research Report
  • [Book] 臨床薬理学2021

    • Author(s)
      朝比奈靖浩
    • Total Pages
      331
    • Publisher
      医学書院
    • Related Report
      2020 Annual Research Report 2019 Annual Research Report
  • [Book] 最新ガイドラインに基づく 消化器疾患診療指針2021-22’2021

    • Author(s)
      朝比奈靖浩
    • Total Pages
      365
    • Publisher
      総合医学社
    • Related Report
      2020 Annual Research Report
  • [Book] 保険総合大百科2020

    • Author(s)
      朝比奈靖浩
    • Total Pages
      287
    • Publisher
      少年写真新聞社
    • Related Report
      2020 Annual Research Report
  • [Book] 日本臨牀 別冊 領域別症候群シリーズ(第3版)2020

    • Author(s)
      朝比奈靖浩
    • Total Pages
      371
    • Publisher
      日本臨牀
    • Related Report
      2020 Annual Research Report
  • [Book] 肝癌診療マニュアル 第4版2020

    • Author(s)
      朝比奈靖浩
    • Total Pages
      278
    • Publisher
      医学書院
    • Related Report
      2020 Annual Research Report
  • [Book] 臨床検査のガイドライン2019

    • Author(s)
      朝比奈靖浩.
    • Total Pages
      473
    • Publisher
      宇宙堂八木書店
    • Related Report
      2019 Annual Research Report
  • [Book] 消化器疾患最新の治療2019-20202019

    • Author(s)
      朝比奈靖浩.
    • Total Pages
      497
    • Publisher
      南江堂
    • Related Report
      2019 Annual Research Report
  • [Book] ウイルス性肝炎2019

    • Author(s)
      朝比奈靖浩
    • Total Pages
      245
    • Publisher
      最新医学社
    • Related Report
      2019 Annual Research Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi